The future of molecular imaging is personal
Connecting every step in molecular medicine
Discovery
Diagnosis
Treatment
The New Future of Molecular Imaging
![GEHC MI Landing Page Updates PET-CT Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-ct-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=3D2E235EC799B8AE3EF151AA810B8C97)
PET/CT
PET/CT Products
![GEHC MI Landing Page Updates PET-CT Image 7](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-ct-image-7.jpg?h=640&iar=0&w=1920&rev=-1&hash=20D63E14AC2A711222910D182359B971)
![GEHC MI Landing Page Updates Nuclear Medicine Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-nuclear-medicine-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=70EE8F4BA6617BE2BC120E40B648A857)
Nuclear Medicine
Nuclear Medicine Products
StarGuide
Introducing StarGuide, our most advanced SPECT/CT featuring advanced Cadmium Zinc Telluride (CZT) technology.MyoSPECT
MyoSPECT, a cardiac-dedicated SPECT designed and engineered to accurately see the story in every heartbeat.NM/CT 870 CZT
NM/CT 870 DR
NM/CT 870 DR, a leading light in clinical discoveryNM/CT 860
NM/CT 860, the ideal balance of CT performance and clinical capabilityNM/CT 850
With NM/CT 850, you don't need the space for a high-end CT to ensure every SPECT image has the valuable perspective of CT.NM 830
NM 830 brings you the diagnostic capability of a dual-head SPECT system.
![GEHC MI Landing Page Updates Nuclear Medicine Image 10](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-nuclear-medicine-image-10.jpg?h=640&iar=0&w=1920&rev=-1&hash=B422258C15A4383DF21BB32B38A9A0AF)
![GEHC MI Landing Page Updates PET Radiopharmacy Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-pet-radiopharmacy-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=BBAC8BF98CDAAEEA61A3BFCA88056C00)
PET Radiopharmacy
Total Gallium. On demand.
PET Radiopharmacy Products
![production-synthesis of PET radiopharmaceutical](/-/jssmedia/gehc/us/images/products/molecular-imaging/production-synthesis-of-pet-radiopharmaceutical.jpg?h=1080&iar=0&w=1920&rev=-1&hash=D891722B5EEBD6B14E4D0F80A9EE2122)
![GEHC MI Landing Page Updates MI Digital Solutions Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-mi-digital-solutions-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=A80EBDCB100308445CF57DCE8D5BE6C4)
MI Digital Solutions
MI Digital Solutions Products
![GEHC MI Landing Page Updates MI Digital Solutions Image 6](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-mi-digital-solutions-image-6.jpg?h=640&iar=0&w=1920&rev=-1&hash=F07C22DAE009224D6816845042879362)
![GEHC MI Landing Page Updates Smart Subscription Image 1](/-/jssmedia/gehc/us/images/products/molecular-imaging/gehc-mi-landing-page-updates-smart-subscription-image-1.jpg?h=640&iar=0&w=1920&rev=-1&hash=8126F29BA1E3C53189A68CF01FACF78A)
Smart Subscription
- MI systems that keep getting better
- Common capabilities at all your sites
- Facilitate staff training and operations
Smart Subscription Products
Articles
1. Radiopharmaceuticals may not be approved by ministers of health in all regions.
2. Source: Global Cancer Statistics 2020: https://doi.org/10.3322/caac.21660